Trazpiroben | Interleukin Related interleukin-related.com

Product Name :
Trazpiroben

Search keywords :
Trazpiroben

drugId :
null

Target Vo:
Dopamine D2 receptor

Target Vo Short Name :
DRD2

Moa_Name:
Dopamine D3 receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Takeda Pharmaceutical Co Ltd

Active Company_Name :
Millennium Pharmaceuticals Inc

Active Indication_Name:
Diabetic Gastroparesis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
JNK1+JNK3 Antibody
Phospho-c-Myc (Ser62) Antibody
ZO-1/TJP1 Antibody: ZO-1/TJP1 Antibody is an unconjugated, approximately 191 kDa, rabbit-derived, anti-ZO-1/TJP1 polyclonal antibody. ZO-1/TJP1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, pig, and predicted: mouse, rat, chicken, dog, cow, rabbit, guinea pig background without labeling.

Author: Interleukin Related

Related Posts